TenNor recevies FDA ODD for treating prosthetic joint infections

China |  News | 0 Comment | 22 Jan, 2020

China based TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designation for TNP-2092 to treat prosthetic joint infections. Medical devi...Read more

Chi-Med to stop pancreatic cancer trial upon early success

China |  News | 0 Comment | 21 Jan, 2020

Hutchison China MediTech has announced that the independent Data Monitoring Committee (“IDMC”) of the Phase III pivotal study of surufatinib in advanced neur...Read more

Mindray to improve diagnostic confidence

China |  News | 0 Comment | 20 Jan, 2020

China headquartered Mindray Medical, a leading global provider of medical devices and solutions, announces the release of its new Point-of-Care Ultrasound System, TE7 ACE. This new Tou...Read more

MEVION S250i Selected for New Proton Therapy Center at Chinese Hospital

China |  News | 0 Comment | 20 Jan, 2020

Mevion Medical Systems has signed an agreement to sell a HyperSCAN® pen-scanning scanner to Jinshazhou Hospital of Guangzhou University of Chinese Medicine MEVION S250i P...Read more

Eisai launches anti cancer agent Halaven in China

China |  News | 0 Comment | 17 Jan, 2020

Japan headquartered Eisai Co., Ltd. has announced that it has launched the in-house developed anticancer agent Halaven® (generic name: eribulin mesylate) in China. Halaven is a ha...Read more

FDF China to boost Chinese pharmaceutical enterprises

China |  News | 0 Comment | 16 Jan, 2020

FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implemen...Read more

WuXi Biologics and Bayer enter into acquisition agreement

China |  News | 0 Comment | 16 Jan, 2020

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and B...Read more

Advances in Cell and Gene Therapy and Opportunities in China

China |  Opinion | 0 Comment | 16 Jan, 2020

GenScript Biotech Corp., a leading global biotechnology group and a pioneer in the field of gene synthesis, held its inaugural "Global Forum on Cell & Gene Therapy and the Booming China...Read more

Tsinghua Amgen Scholars Program 2020 calls for application

China |  News | 0 Comment | 15 Jan, 2020

The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for stud...Read more

PPD expands clinical capabilities in China

China |  News | 0 Comment | 15 Jan, 2020

PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chinese biopharmaceutical companies with more Comprehensive clinical deve...Read more

Great Bay Bio injected with $2.5M of convertible note

China |  News | 0 Comment | 14 Jan, 2020

Recently, Great Bay Bio signed off convertible note, and the company will be injected with 2.5 million USD by existing shareholders, which including renowned financial institute and family ...Read more

Adagene Completes $69 Million Series D Financing

China |  News | 0 Comment | 14 Jan, 2020

China based Adagene, Inc., a clinical-stage, leading-edge oncology immunotherapy company driven by a powerful antibody discovery and engineering platform, has announced the completion of a ...Read more

EUSA Pharma, BeiGene partner for rare disease drug development

China |  News | 0 Comment | 14 Jan, 2020

EUSA Pharma and BeiGene has announced that they have entered into an exclusive development and commercialization agreement for the orphan biologic products SYLVANT (siltuximab) an...Read more

Bio-Thera launches first Humira biosimilar in China

China |  News | 0 Comment | 13 Jan, 2020

Bio-Thera Solutions, Ltd., a fully-integrated pharmaceutical company, has announced that QLETLI®, a biosimilar to Humira® (adalimumab), is now available in China. QLETLI®&n...Read more

WuXi Biologics inks strategic deal with Almirall in derma space

China |  News | 0 Comment | 10 Jan, 2020

China based WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Spai...Read more

Former Celgene Chairman and CEO Joins Antengene Board of Directors

China |  News | 0 Comment | 09 Jan, 2020

The Antengene board has announced the appointment of Mr. Mark J. Alles as an independent director of the company, effective January 2, 2020. Mr. Alles is the former Chairman ...Read more

Eisai launches antiepileptic drug in China

China |  News | 0 Comment | 09 Jan, 2020

Japan based Eisai Co., Ltd. has announced that it has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa®, for use in adjunctive treatment of partial onset ...Read more

CStone initiates CS1001 trial to treat ESCC in China

China |  News | 0 Comment | 08 Jan, 2020

CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Company's anti-PD-L1 antibody CS1001 in combination therapy as fir...Read more